Sex and hepatitis B virus (HBV) infection are both important risk factors for primary liver cancer. However, their possible biologic interaction has not been well studied. The authors examined data from 89,789 subjects aged 25-69 years who participated in a 14-year cohort study (1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006) conducted in Haimen, China. An agestratified Cox proportional hazards model was used for multivariate analysis. The authors assessed the combined effect of sex and HBV infection on liver cancer mortality by calculating 3 interaction measures: the relative risk due to interaction, the attributable proportion of interaction, and the synergy index. There was a greater risk difference between hepatitis B surface antigen carriers and noncarriers among men than among women. After adjustment for potential confounders, the relative risk due to interaction, the attributable proportion of interaction, and the synergy index were 33.27 (95% confidence interval (CI): 22.54, 43.99), 0.59 (95% CI: 0.55, 0.63), and 2.49 (95% CI: 2.13, 2.90), respectively, suggesting a significant synergistic effect of the interaction between sex and HBV infection on liver cancer mortality. HBV infection had a larger impact on liver cancer mortality in men than in women, which may explain at least part of the sex difference in liver cancer risk.
Hepatocellular carcinoma represents the majority of cases of primary liver cancer (hereafter called liver cancer); it is the fifth most common cancer and the third leading cause of cancer death worldwide (1, 2) . China is one of the countries with the highest incidence of hepatocellular carcinoma in the world-approximately 35 cases per 100,000 population for males and 13 per 100,000 for females (2) . Hepatocellular carcinoma is a male-predominant cancer, with a male:female ratio ranging from 2:1 to 4:1 (2) . Hepatitis B virus (HBV) infection, which is endemic in many Asian countries, including China, is a leading risk factor for hepatocellular carcinoma and accounts for approximately 53% of hepatocellular carcinoma cases worldwide (3) . Other important risk factors for hepatocellular carcinoma include hepatitis C virus infection, alcoholism, aflatoxin B 1 ingestion, and family history of liver cancer (4) . So far, it has been unclear whether HBV infection can explain the sex difference in the occurrence of liver cancer. In this study, we examined effect modification by sex of the association between HBV infection and liver cancer mortality, based on data from a 14-year longitudinal study conducted in Haimen, China.
MATERIALS AND METHODS

Study population
Study methods have been described in detail previously (5) . Briefly, the study was started in February 1992 in Haimen, China, and enrollment continued until December 1993. A total of 90,236 residents (60,306 men and 29,930 women) voluntarily participated. The subjects were 22-80 years of age. All of the participants completed a questionnaire and provided a blood specimen at entry. The questionnaire collected information about name, residence, date of birth, occupation (peasant, nonpeasant), regular cigarette smoking (daily), regular alcohol drinking (!4 drinks per week), regular tea drinking (!4 times per week), past pesticide exposure, drinking water source (ditch, pond, shallow well, deep well) in every decade from the 1960s to the 1990s, staple food type (corn, rice, wheat) in every decade from the 1960s to the 1990s, history of acute hepatitis, history of jaundice, history of cirrhosis, and family history of liver cancer. The subjects were tested for hepatitis B surface antigen (HBsAg) by radioimmunoassay.
The study protocol was approved by the Institutional Review Board of Fox Chase Cancer Center (Philadelphia, Pennsylvania), the Medical Ethics Review Group of Haimen City (Haimen, China), and the Ethics Review Committee of Shanghai Medical University (Shanghai, China). Questionnaire data were collected by trained interviewers employed at the Haimen City Anti-Epidemic Station. In this analysis, we included all 89,789 participants (60,076 men and 29,713 women) who were aged 25-69 years at entry.
All of the subjects were followed up every year for vital status and liver cancer mortality until December 31, 2006. Death certification information was reported to the death register system at Haimen City Anti-Epidemic Station monthly by village or township doctors. Information on cause of death for persons who had temporarily moved out of Haimen was also collected. Persons who had a permanent change of residency were identified and no longer followed.
Statistical analysis
Person-years of follow-up were calculated for each participant from the date of the baseline survey to the date of death, the date of loss to follow-up, or, if neither of those events occurred, the end of the study period (December 31, 2006) . Subjects who were lost to follow-up were censored on the last confirmed date of their presence in Haimen. A Cox proportional hazards model was used to estimate the sex-specific hazard ratio and 95% confidence interval for liver cancer mortality associated with HBsAg status. Time-dependent covariates were used to assess proportionality. The baseline hazard in the proportional hazards regression models was stratified by 1-year age category, and then the proportional hazards assumption for the other variables was satisfied. Estimated hazard ratios were adjusted for other potential confounders, including occupation, cigarette smoking, alcohol consumption, history of hepatitis, and family history of liver cancer.
The modifying effect of sex on the relation between HBsAg and liver cancer mortality was examined on a multiplicative scale; it was not statistically significant in a previous analysis (5) and also was not significant in this study. It has been argued that interaction on an additive scale is more meaningful for assessing public health and biologic significance (6, 7) and also more indicative of the underlying causal mechanism (8) . In this analysis, we assessed the effect of the additive interaction of HBsAg status and sex on risk of liver cancer mortality. We calculated 3 measures (9, 10)-the relative excess risk of interaction (RERI) (calculated as RR AþBþ À RR AþBÀ À RR AÀBþ þ 1), the attributable proportion of interaction (calculated as RERI/RR AþBþ ), and the synergy index (calculated as (RR AþBþ À1)/ [(RR AþBÀ À 1) þ (RR AÀBþ À 1)])-and their 95% confidence intervals to assess the combined effect of male sex and HBV infection as measured by HBsAg status. Subjects were grouped into 4 categories: females who were HBsAg-negative (AÀBÀ), females who were HBsAg-positive (AþBÀ), males who were HBsAg-negative (AÀBþ), and males who were HBsAgpositive (AþBþ). If there is no interaction, RERI and the attributable proportion of interaction are both 0 and the synergy index is 1 (9) .
Statistical analysis was performed using the Statistical Analysis System, version 9.1 (SAS Institute, Inc., Cary, North Carolina). The SAS program provided by Li and Chambless (11) was used to calculate the 3 measures of additive interaction and to test for significance.
RESULTS
The 89,789 subjects had a total of 1,147,713 person-years of follow-up. Table 1 shows the demographic characteristics of the participants at baseline. Among the subjects, 15.8% were HBsAg-positive (men: 15.3%; women: 16.9%). A total of 13,529 deaths or losses to follow-up were identified, among which 1,803 participants died from liver cancer, with 73.7% of them being HBsAg-positive. The median age at death for liver cancer patients was 51.7 years for men and 52.4 years for women. Mortality from liver cancer varied in the 4 groups defined by sex and HBsAg status ( Table 2 ). Male HBsAg carriers had the highest liver cancer mortality (1,035.2 deaths per 100,000 person-years), while female non-HBsAg carriers had the lowest (16.1 deaths per 100,000 person-years). The mortality difference for liver cancer between HBsAg carriers and non-HBsAg carriers was much greater in men than in women among all age groups.
HBsAg carriers had an increased risk of mortality from liver cancer, with a hazard ratio of 16 as compared with nonHBsAg carriers. Male sex and older age were also important predictors of liver cancer mortality. Compared with women who were HBsAg-negative, mortality was significantly increased in males and persons who were HBsAg-positive, and the combined effect of male sex and HBsAg positivity was synergistic (Figure 1 ). After adjustment for potential confounders, the 3 interaction measures on the additive scale all showed significantly higher values than the null (RERI: 33.27 (95% confidence interval (CI): 22.54, 43.99); attributable proportion of interaction: 0.59 (95% CI: 0.55, 0.63); synergy index: 2.49 (95% CI: 2.13, 2.90)), suggesting a synergistic effect of male sex and HBsAg positivity on liver cancer mortality. We further examined this joint effect according to age (Table 3 ). The RERI decreased with increasing age, suggesting that the sex-HBsAg interaction was stronger in younger people. 
DISCUSSION
It has been well documented that men are more likely than women to develop liver cancer (2) , and HBV infection is a major risk factor (3) . In this analysis, we focused on the joint effect of male sex and HBV infection on liver cancer mortality. The proportion of HBsAg-positive men was comparable to that of women in our study. It has been suggested that the higher rate of liver cancer in males than in females is due to higher levels of exposure to risk factors (2). However, after adjustment for covariates, including HBsAg status, age, history of hepatitis, occupation, regular alcohol drinking, regular cigarette smoking, and family history of liver cancer, men still had higher mortality from liver cancer than women did. This may suggest that some susceptibility other than exposure level is more important.
We assessed additive interaction by calculating 3 measures, including RERI, the attributable proportion of interaction, and the synergy index, all of which indicated that there was a significant synergistic effect of HBsAg positivity and male sex on risk of liver cancer mortality. HBsAg positivity had an increased effect on liver cancer mortality in men compared with women. RERI, considered the best measure of additivity in the hazards model (11) , indicated that the excess risk for male HBsAg carriers due to interaction was 33 times higher than the risk for female nonHBsAg carriers. A high proportion (59%) of the mortality among male HBsAg carriers was attributable to the interaction. Because of the additive interaction, the excess risk of liver cancer mortality resulting from combined exposure to male sex and HBsAg positivity was 2.49 times higher than the sum of their independent effects. These results suggest that men are more sensitive to the effect of HBV infection on liver cancer mortality than women. An increased impact of HBV infection may explain, at least in part, the elevated risk of liver cancer in men.
Many studies have explored potential mechanisms of liver cancer development, as well as the sex difference in incidence. Sex hormones may play an important role in sex disparity in the process of oncogenesis. In a multicenter case-control study, Yu et al. (12) observed an inverse relation between exposure to estrogen and liver cancer, suggesting that estrogen may provide a protective effect against liver cancer. Naugler et al. (13) found that estrogenmediated inhibition of interleukin-6 production by Kupffer cells reduced the risk of liver cancer in females. An intracellular signaling protein called MyD88 and the transcription factor nuclear factor jB were also found to be involved in this signaling pathway (13, 14) . Wang et al. (15) integrated the HBsAg gene into the mouse p21 neomycin locus and found that estrogen receptor b was extremely up-regulated, which indicates that estrogen receptor b may play an important role in the development of liver cancer related to HBsAg. In a case-control study, Yu et al. (16) and Sung et al. (17) found that there was a positive association between testosterone levels and liver cancer risk in HBV carriers and that genes involved in the regulation of testosterone, such as SRD5A2 and V89L, may also play a role in the etiology of liver cancer.
Liver cancer arises most frequently in the setting of chronic liver inflammation (18) . After infection by the hepatitis virus, the host's inflammatory immune response to the viral antigens induces hepatocyte damage and is followed by the pathogenesis of liver cancer (19) . Sex hormones may interact with HBV infection in the process and lead to a dominant sex disparity in liver cancer risk. In our analysis, the sex-HBsAg interaction tended to decrease with age. Previous study has demonstrated that liver cancer tends to occur in men and postmenopausal women, which may result from lower production of estradiol and a reduced response to the action of estradiol (20) . That may contribute to a lower sex disparity in the HBV-related risk of liver cancer in older people. Another possibility is potentially competing causes of death, which may be more prominent in older subjects than in younger ones and is also sex-related.
One limitation of our study is that HBsAg status was used as the sole indicator of HBV infection. Occult HBV infection, a type of chronic HBV infection that is characterized by the absence of detectable HBsAg in the blood and very low levels of HBV DNA in the blood and liver (21, 22) , can also lead to liver cancer, with a mechanism similar to that of overt cases (23) . Therefore, part of the mortality among HBsAg noncarriers might be attributable to the effect of occult hepatitis B infection, resulting in underestimation of the effect of HBV infection as well as its interaction with sex. Additional data on HBV infection, such as information on hepatitis B e antigen, HBV virus load, and HBV genotype, would consolidate the finding (3, 23) .
In summary, we found a synergistic effect of male sex and HBV infection on risk of liver cancer mortality, suggesting that HBV infection may have a greater impact on liver cancer risk in men than in women, at least for persons living in high-risk areas. Possible mechanisms for the interaction between sex and HBV infection in liver cancer mortality need to be further explored. If the finding is confirmed by other studies, a specific HBV vaccination program may be developed to reduce liver cancer risk. It has been well demonstrated that HBV infection frequently occurs as a result of vertical (mother-to-child) or horizontal (child-to-child) transmission in endemic areas (24) . It has also been reported that HBV infection can be acquired in adulthood through invasive medical procedures or household contact with HBV carriers (25) . In Haimen, where the current study was conducted, an HBV vaccination program for all newborns was implemented in 1992. Adults, however, are not included in the program. Because of the increased risk of liver cancer in HBsAg-positive males, immunization strategies might be expanded to also include male adults not yet infected with HBV, to reduce the risk of developing liver cancer.
